Delivery Order SPE2DB22D2206-SPE2DB24FJV00

Award Date 8/15/24
Potential Completion Date 9/6/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XALKORI 250 MG CAPSULE 60S. The contract has a ceiling value of $12,877.79 and is a firm fixed price delivery order. The ultimate completion date for this contract is October 21, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,356.89 firm fixed-price contract is for the delivery of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product, with a ceiling value of $28,713.78 and a period of performance through June 17, 2025. The contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $14,356.89 firm fixed price contract is for the delivery of XALKORI 250 MG CAPSULE 60S, with a performance period through June 2025. The contract is not set aside and allows for the provision of a wide range of pharmaceutical and medical products to support military healthcare programs....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $12,865.21 firm-fixed-price contract is for the supply of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, to support federal healthcare programs. The contract does not have a set-aside designation and has an ultimate completion date of September 24, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,549,264 units of the pharmaceutical product XALKORI 250 MG CAPSULE 60S. The contract has a completion date of February 27, 2024 and a potential value of $12,877.79. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $12,877.79 firm-fixed price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4565262000 XALKORI 250 MG CAPSULE 60S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to military treatment facilities worldwide....
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,419.30 contract is for the delivery of XALKORI 200 MG CAPSULE 60S, a pharmaceutical product, with a completion date of July 8, 2025. The contract is not set aside and allows for the supply of a wide range of pharmaceutical and medical products to support military healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,356.89 and is for the supply of XALKORI 250 MG CAPSULE 60S, a prescription medication. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of XALKORI 250 MG CAPSULE 60S, a pharmaceutical product, with a ceiling value of $14,356.89 and a period of performance through July 23, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside for any specific business type....
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJV00
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 4,565,470 units of the prescription drug XALKORI 250 MG CAPSULE 60S, with a ceiling value of $12,877.79. The contract has an ultimate completion date of September 6, 2024.

AmerisourceBergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range of medical commodities, including prescription drugs, medical supplies, and equipment. These IDCs serve as primary vehicles for government agencies to efficiently procure essential pharmaceutical and medical products to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. This particular delivery order is not designated as a set-aside contract.

Generated 11/14/24, 9:17 AM